NLM Digital Collections

Search

Start Over Authors Synnott, Patricia, author ✖Remove constraint Authors: Synnott, Patricia, author

1. CardioMEMS (tm) HF System (St. Jude Medical, Inc.) and Sacubitril/Valsartan (Entresto (tm), Novartis AG) for management of congestive heart failure: effectiveness, value, and value-based price benchmarks : final report

Author(s):
Ollendorf, Daniel A., author
Ollendorf, Daniel A., author
Tarlochan Sandhu, Alexander, author
Chapman, Rick, author
Heidenreich, Paul A., author
Russo, Elizabeth, author
Shore, Karen K., author
Synnott, Patricia, author
Travers, Karin, author
Weissberg, Jed, author
Pearson, Steven D., author
Publication:
[Boston, MA] : Institute for Clinical and Economic Review, December 1, 2015
Subject(s):
Angiotensin II Type 1 Receptor Blockers -- administration & dosage
Antihypertensive Agents -- administration & dosage
Blood Pressure Monitoring, Ambulatory -- instrumentation
Blood Pressure Monitoring, Ambulatory -- methods
Heart Failure -- diagnosis
Heart Failure -- drug therapy
Neprilysin -- administration & dosage
Tetrazoles -- administration & dosage
Valsartan -- administration & dosage
Angiotensin II Type 1 Receptor Blockers -- economics
Antihypertensive Agents -- economics
Cost-Benefit Analysis
Drug Combinations
Drug Costs
Neprilysin -- antagonists & inhibitors
Neprilysin -- economics
Outcome and Process Assessment (Health Care)
Tetrazoles -- economics
Valsartan -- economics
Humans
United States

2. Controversies in obesity management: a technology assessment : final report

Author(s):
Ollendorf, Daniel A., author
Shore, Karen K., author
Cameron, Chris, author
Weissberg, Jed, author
Loos, Anne M., author
Synnott, Patricia, author
Pearson, Steven D., author
Publication:
[Boston, MA] : Institute for Clinical and Economic Review, August 10, 2015
Subject(s):
Disease Management
Obesity -- therapy
Anti-Obesity Agents
Bariatric Surgery -- economics
Bariatric Surgery -- statistics & numerical data
Body Mass Index
Comparative Effectiveness Research
Cost-Benefit Analysis
Insurance Coverage
Obesity -- complications
Obesity -- etiology
Obesity -- prevention & control
Practice Guidelines as Topic
Technology Assessment, Biomedical
Weight Loss
Humans
United States

3. Siponimod for the treatment of secondary progressive multiple sclerosis: effectiveness and value : final evidence report

Author(s):
Sharaf, Ravi, author
Synnott, Patricia, author
Samur, Sumeyye, author
Chapman, Rick M., author
Adair, Ellie, author
Rind, David, author
Pearson, Steve, author
O'Grady, Madeline, author
Bloudek, Lisa, author
Carlson, Josh J., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, June 20, 2019
Subject(s):
Multiple Sclerosis, Chronic Progressive -- drug therapy
Sphingosine 1 Phosphate Receptor Modulators
United States